Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mel Sorensen currently holds 195,029 shares of Galera Therapeutics, Inc. (GRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mel Sorensen has been a net buyer of GRTX stock. They have purchased $168.0K and sold $6.1K worth of shares.
Mel Sorensen's most recent insider trade was on Nov 20, 2025, when they sold 70,000 shares at $0.02 per share.
Mel Sorensen serves as Executive at Galera Therapeutics, Inc. (GRTX). They have executed 5 insider transactions totaling $174.1K over their tenure at the company.
Mel Sorensen holds the position of Executive at Galera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Mel Sorensen has shown a buying trading pattern, with $168.0K in total purchases and $6.1K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mel Sorensen was on Mar 26, 2021, when they sold $182.0K worth of GRTX shares. This transaction involved 170,075 shares at $1.07 per share.
Mel Sorensen currently owns 195,029 shares of Galera Therapeutics, Inc. (GRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mel Sorensen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mel Sorensen has 5 Form 4 filings on record as an insider at Galera Therapeutics, Inc..
Set alerts for Mel Sorensen and 40,000+ other insiders.